We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Policy.
San Diego — Opioid use related to workers’ compensation claims decreased nearly 10% in 2023, marking one of the largest drops the workers’ comp industry has seen in years, according to a new report.
Secaucus, NJ — The percentage of U.S. workers whose drug test showed signs of tampering skyrocketed in 2023 to its highest level in over 30 years, according to Quest Diagnostics’ annual Drug Testing Index.
Washington — The White House wants to help employers support workers who are dealing with substance misuse – as well as those in recovery. As part of the effort, the Office of National Drug Control Policy has released a toolkit.
Itasca, IL — The National Safety Council is raising awareness of over-the-counter naloxone nasal spray for emergency treatment of opioid overdoses in the workplace.
Washington — The approval of a second over-the-counter naloxone nasal spray for emergency treatment of a known or suspected opioid overdose is a “game-changer” for its lifesaving potential, the National Safety Council says.
Washington — The opioid epidemic has had a wide-ranging impact on U.S. workers, but employers who support recovery can help, a new policy report states.
Surrey, British Columbia — For people who are prescribed opioids to treat injury-related pain, experiencing their injury on the job may have a “protective effect” against the risk of future drug overdose.